Who
Shulamit Ron-Bigger
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Aktis Oncology.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $2.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Jul 2026
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Jul – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Code M | $183K50,000 at $3.66 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $429K15,800 at $27.13 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $838K30,000 at $27.94 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $121K4,200 at $28.75 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Code M | $183K50,000 at $3.66 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $429K15,800 at $27.13 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $838K30,000 at $27.94 | filing |
| 8 Jul 2026filed 10 Jul 2026 | AKTS Aktis OncologyBiotechnology | SEC FORM 4 Sold | $121K4,200 at $28.75 | filing |
News
PTC Therapeutics (NASDAQ:PTCT) & Aktis Oncology (NASDAQ:AKTS) Head to Head ContrastAKTS · dailypolitical.com · 19 Oct 2026
0 headlines in the last 90 days name Shulamit Ron-Bigger; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.